Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
PROCEPT BioRobotics

PROCEPT BioRobotics (NASDAQ: PRCT) insider transactions

In the twelve months to 10 November 2026, executives and directors of PROCEPT BioRobotics reported 15 open-market sales of 29,982 shares ($716,672) and 8 open-market purchases of 450,162 shares ($11.0m), by 6 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in PROCEPT BioRobotics shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
6 November 2026Sharma PoojaChief Strat/Marketing OfficerOpen-market sale−4,710$19.71106,471Form 4
2 October 2026Mack MichaelDirectorGrant or award+7,727—7,727Form 4
9 September 2026Templin Barry LEVP, Chief Technology OfficerOpen-market sale−373$20.9594,826Form 4
9 September 2026Nouri AlalehEVP, Clo, Corp. Sec.Open-market sale−297$20.95127,737Form 4
9 September 2026Waters KevinEVP, CFOOpen-market sale−373$20.95180,355Form 4
13 August 2026Sharma PoojaChief Strat/Marketing OfficerGrant or award+23,622—111,181Form 4
13 August 2026Waters KevinEVP, CFOGrant or award+29,527—180,728Form 4
13 August 2026Templin Barry LEVP, Chief Technology OfficerGrant or award+26,246—95,199Form 4
13 August 2026Nouri AlalehEVP, Clo, Corp. Sec.Grant or award+22,965—128,034Form 4
7 August 2026Wood Larry LPresident, CEOOpen-market purchase+23,900$20.8523,900Form 4
9 June 2026Puckett DanDirectorGrant or award+3,315—8,791Form 4
9 June 2026Prescott Thomas MDirectorGrant or award+3,315—7,211Form 4
9 June 2026Moll Frederic HDirectorGrant or award+3,315—866,474Form 4
9 June 2026Little Elisabeth SandovalDirectorGrant or award+3,315—15,876Form 4
9 June 2026Harris Taylor C.DirectorGrant or award+3,315—102,491Form 4
9 June 2026Garrett MaryDirectorGrant or award+3,315—17,700Form 4
9 June 2026Dodrill Amy M.DirectorGrant or award+3,315—10,941Form 4
9 June 2026Desai Antal RohitDirectorGrant or award+3,315—38,467Form 4
8 June 2026Templin Barry LEVP, Chief Technology OfficerOpen-market sale−358$28.4868,953Form 4
8 June 2026Waters KevinEVP, CFOOpen-market sale−357$28.48151,201Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the PROCEPT BioRobotics page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.